Works matching DE "AFLIBERCEPT"
Results: 339
A cost-minimization analysis of anti-VEGFs for the treatment of neovascular age-related macular degeneration in the Netherlands.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2025, v. 263, n. 2, p. 327, doi. 10.1007/s00417-024-06588-6
- By:
- Publication type:
- Article
Near vision in patients with DME and RVO treated with aflibercept and correlation with NEI VFQ-25 questionnaire.
- Published in:
- International Journal of Retina & Vitreous, 2024, v. 10, n. 1, p. 1, doi. 10.1186/s40942-024-00558-0
- By:
- Publication type:
- Article
Comparison of antiangiogenic agents (ranibizumab, aflibercept, bevacizumab and ziv-aflibercept) in the therapeutic response to the exudative form of age-related macular degeneration according to the treat-and-extend protocol- true head-to-head study.
- Published in:
- International Journal of Retina & Vitreous, 2024, v. 10, n. 1, p. 1, doi. 10.1186/s40942-024-00537-5
- By:
- Publication type:
- Article
Correlations between subfoveal choroidal thickness, macular thickness, and visual outcome in neovascular age-related macular degeneration using swept source OCT: insights from intravitreal aflibercept treatment.
- Published in:
- International Journal of Retina & Vitreous, 2023, v. 9, n. 1, p. 1, doi. 10.1186/s40942-023-00506-4
- By:
- Publication type:
- Article
A customized regimen of intravitreal aflibercept for the treatment of choroidal neovascularization secondary to different chorioretinal diseases.
- Published in:
- International Journal of Retina & Vitreous, 2023, v. 9, n. 1, p. 1, doi. 10.1186/s40942-023-00440-5
- By:
- Publication type:
- Article
Intravitreal sirolimus with adjunct aflibercept versus aflibercept monotherapy for persistent, exudative age-related macular degeneration: a pilot study.
- Published in:
- International Journal of Retina & Vitreous, 2023, v. 9, n. 1, p. 1, doi. 10.1186/s40942-022-00437-6
- By:
- Publication type:
- Article
Intravitreal aflibercept for the treatment of patients with neovascular age-related macular degeneration in routine clinical practice in Latin America: the AQUILA study.
- Published in:
- International Journal of Retina & Vitreous, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s40942-022-00425-w
- By:
- Publication type:
- Article
Pro re nata versus fixed aflibercept regimen for neovascular age-related macular degeneration: a systematic review and meta-analysis.
- Published in:
- International Journal of Retina & Vitreous, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s40942-022-00416-x
- By:
- Publication type:
- Article
Intravitreal aflibercept for the treatment of patients with diabetic macular edema in routine clinical practice in Latin America: the AQUILA study.
- Published in:
- International Journal of Retina & Vitreous, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s40942-022-00396-y
- By:
- Publication type:
- Article
Efficacy and safety of brolucizumab versus aflibercept in patients with neovascular age-related macular degeneration: a randomized trial in Indian patients.
- Published in:
- International Journal of Retina & Vitreous, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s40942-022-00401-4
- By:
- Publication type:
- Article
Accuracy of intravitreal injection volume for aflibercept pre-filled syringe and BD Luer-Lok one-milliliter syringe.
- Published in:
- International Journal of Retina & Vitreous, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s40942-022-00375-3
- By:
- Publication type:
- Article
Functional and structural characteristics in patients with diabetic macular oedema after switching from ranibizumab to aflibercept treatment. Three year results in real world settings.
- Published in:
- International Journal of Retina & Vitreous, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s40942-022-00373-5
- By:
- Publication type:
- Article
Long term results of patients with neovascular age-related macular degeneration switched from other anti-VEGF agents to intravitreal Aflibercept.
- Published in:
- International Journal of Retina & Vitreous, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s40942-022-00361-9
- By:
- Publication type:
- Article
Intravitreal aflibercept following treat and extend protocol versus fixed protocol for treatment of neovascular age-related macular degeneration.
- Published in:
- International Journal of Retina & Vitreous, 2021, v. 7, n. 1, p. 1, doi. 10.1186/s40942-021-00349-x
- By:
- Publication type:
- Article
Comparison of aflibercept and bevacizumab in the treatment of type 1 retinopathy of prematurity.
- Published in:
- International Journal of Retina & Vitreous, 2021, v. 7, n. 1, p. 1, doi. 10.1186/s40942-021-00334-4
- By:
- Publication type:
- Article
Pipeline therapies for neovascular age related macular degeneration.
- Published in:
- International Journal of Retina & Vitreous, 2021, v. 7, n. 1, p. 1, doi. 10.1186/s40942-021-00325-5
- By:
- Publication type:
- Article
Visual and anatomical outcomes associated with treat-and-extend administration of intravitreal aflibercept for neovascular age-related macular degeneration.
- Published in:
- International Journal of Retina & Vitreous, 2021, v. 7, n. 1, p. 1, doi. 10.1186/s40942-021-00326-4
- By:
- Publication type:
- Article
Aflibercept clearance through the drainage system in a rat model.
- Published in:
- International Journal of Retina & Vitreous, 2021, v. 7, n. 1, p. 1, doi. 10.1186/s40942-021-00322-8
- By:
- Publication type:
- Article
A comparation of three different anti-VEGF drugs in development of persistent avascular retina in premature children.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-82445-0
- By:
- Publication type:
- Article
A pilot study : retinal sensitivity change in neovascular age-related macular degeneration patients with better baseline visual acuity.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-77485-5
- By:
- Publication type:
- Article
Comparison of the efficacy and safety of SCD411 and reference aflibercept in patients with neovascular age-related macular degeneration.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-65815-6
- By:
- Publication type:
- Article
Effects of switching from intravitreal injection of aflibercept to faricimab on ocular blood flow in patients with diabetic macular edema.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-63435-8
- By:
- Publication type:
- Article
Differences between pathologic and non-pathologic high myopia in 4-year outcomes of anti-VEGF therapy for macular neovascularization.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-64456-z
- By:
- Publication type:
- Article
Comparative study on the efficacy of Conbercept and Aflibercept in the treatment of neovascular age-related macular degeneration.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-62536-8
- By:
- Publication type:
- Article
Retinal and choroidal efficacy of switching treatment to faricimab in recalcitrant neovascular age related macular degeneration.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-59632-0
- By:
- Publication type:
- Article
Diversity when interpreting evidence in network meta-analyses (NMAs) on similar topics: an example case of NMAs on diabetic macular oedema.
- Published in:
- Systematic Reviews, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s13643-023-02349-4
- By:
- Publication type:
- Article
Tocilizumab and Aflibercept as a Treatment Option for Refractory Macular Edema after Acute Retinal Necrosis.
- Published in:
- Ocular Immunology & Inflammation, 2023, v. 31, n. 1, p. 242, doi. 10.1080/09273948.2021.2024580
- By:
- Publication type:
- Article
OCT Angiography Study of the Macula in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Comparison of Ranibizumab versus Aflibercept in Treating Macular Edema among Patients with Serous Retinal Detachment Secondary to Branch Retinal Vein Occlusion.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Aflibercept for long-term treatment of diabetic macular edema and proliferative diabetic retinopathy: a meta-analysis.
- Published in:
- Frontiers in Endocrinology, 2023, p. 1, doi. 10.3389/fendo.2023.1144422
- By:
- Publication type:
- Article
Intravitreal injections with anti-VEGF agent aflibercept versus subthreshold micropulse laser for chronic central serous chorioretinopathy: the alternative treatment regimens for verteporfin-shortage in China.
- Published in:
- Annals of Medicine, 2023, v. 55, n. 1, p. 1, doi. 10.1080/07853890.2023.2227424
- By:
- Publication type:
- Article
Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy.
- Published in:
- PLoS ONE, 2020, v. 15, n. 2, p. 1, doi. 10.1371/journal.pone.0229231
- By:
- Publication type:
- Article
Intravitreal Brolucizumab and Aflibercept for Polypoidal Choroidal Vasculopathy.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2023, v. 39, n. 9, p. 653, doi. 10.1089/jop.2023.0030
- By:
- Publication type:
- Article
Correction to: Duration of Vascular Endothelial Growth Factor Suppression After Intravitreal Injection of Brolucizumab and Aflibercept in Macaque Eyes, by Obata et al. J. Ocul. Pharmacol. Ther 2023;39(3):225–228. DOI: 10.1089/jop.2022.0160.
- Published in:
- 2023
- Publication type:
- Correction Notice
Duration of Vascular Endothelial Growth Factor Suppression After Intravitreal Injection of Brolucizumab and Aflibercept in Macaque Eyes.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2023, v. 39, n. 3, p. 225, doi. 10.1089/jop.2022.0160
- By:
- Publication type:
- Article
Ocular Pharmacokinetic Properties of Intravitreally Injected Aflibercept in Rabbits After Using Brinzolamide/Timolol Eye Drops.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2023, v. 39, n. 3, p. 229, doi. 10.1089/jop.2022.0146
- By:
- Publication type:
- Article
Five-Year Reactivation After Ranibizumab or Aflibercept Treatment for Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Sustained Anti-Vascular Endothelial Growth Factor Activity of Aflibercept (Eylea) After Storage in Polycarbonate Syringes Used for Intravitreal Injection: A Pathway to Safety and Efficiency.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group.
- Published in:
- Journal of Cancer Research & Therapeutics, 2022, v. 18, p. 347, doi. 10.4103/jcrt.jcrt_1104_21
- By:
- Publication type:
- Article
Therapeutic effect of simultaneous intravitreal dexamethasone and aflibercept on diabetic macular edema.
- Published in:
- Acta Diabetologica, 2022, v. 59, n. 4, p. 501, doi. 10.1007/s00592-021-01824-5
- By:
- Publication type:
- Article
Cytokine Profiles and the Effect of Intravitreal Aflibercept Treatment on Experimental Choroidal Neovascularization.
- Published in:
- Ophthalmic Research, 2022, v. 65, n. 1, p. 68, doi. 10.1159/000513588
- By:
- Publication type:
- Article
Differences in Uptake and Intracellular Fate between Bevacizumab and Aflibercept after Repetitive Long-Term Treatment in the Retinal Pigment Epithelium.
- Published in:
- Ophthalmic Research, 2021, v. 64, n. 3, p. 369, doi. 10.1159/000511960
- By:
- Publication type:
- Article
Clinical Characteristics of Punctate Hyperfluorescence Spots in the Fellow Eye of Patients with Unilateral Macular Neovascularization with No Drusen.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 18, p. 5394, doi. 10.3390/jcm13185394
- By:
- Publication type:
- Article
Inflammation and Vasculitis Related to Brolucizumab.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 17, p. 5208, doi. 10.3390/jcm13175208
- By:
- Publication type:
- Article
Switching to Intravitreal Brolucizumab after Ranibizumab or Aflibercept Using Treat and Extend Regimen for Neovascular Age-Related Macular Degeneration in Japanese Patients: 1-Year Results and Factors Associated with Treatment Responsiveness.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 15, p. 4375, doi. 10.3390/jcm13154375
- By:
- Publication type:
- Article
Short-Term Real-World Outcomes of Intensive Aflibercept Injection for Refractory Neovascular Age-Related Macular Degeneration.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 12, p. 3503, doi. 10.3390/jcm13123503
- By:
- Publication type:
- Article
Switching from a Fixed Monthly Aflibercept Regimen to Bi-Monthly Brolucizumab in Refractory Cases of Neovascular Age-Related Macular Degeneration.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 12, p. 3434, doi. 10.3390/jcm13123434
- By:
- Publication type:
- Article
Real-World Experience with Brolucizumab Compared to Aflibercept in Treatment-Naïve and Therapy-Refractory Patients with Diabetic Macular Edema.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 6, p. 1819, doi. 10.3390/jcm13061819
- By:
- Publication type:
- Article
Comparison of Loading Dose between Aflibercept and Faricimab for Neovascular Age-Related Macular Degeneration.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 2, p. 385, doi. 10.3390/jcm13020385
- By:
- Publication type:
- Article
Fixed Quarterly Dosing of Aflibercept after Loading Doses in Neovascular Age-Related Macular Degeneration in Chinese Eyes.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 1, p. 145, doi. 10.3390/jcm13010145
- By:
- Publication type:
- Article